IRVINE, Calif., May 15, 2019 /PRNewswire/ -- Edwards Lifesciences
Corporation (NYSE: EW), the global leader in patient-focused
innovations for structural heart disease and critical care
monitoring, today announced that the Every Heartbeat Matters
signature charitable initiative is on schedule to meet its goal of
impacting the global burden of heart valve disease. The initiative,
which involves the education, screening and treatment of 1.5
million underserved people by 2020, is supported by grants from
Edwards Lifesciences Foundation, donations of Edwards heart valve
technologies, volunteer support and the dedicated work of 60
non-profit partners.
"Since the Every Heartbeat Matters initiative began five years
ago, we have made substantial progress in building a global
community that is addressing the burden of heart valve disease for
underserved people," said Amanda
Fowler, executive director, Edwards Lifesciences Foundation.
"This year, we plan to continue growing our giving focused on Every
Heartbeat Matters and deepening our partners' impact with the
engagement of our talented and dedicated employees around the
world."
Originally estimated to reach 1 million underserved people by
2020, the Every Heartbeat Matters community exceeded the goal
early, and, in September 2018, raised
it to 1.5 million people. By 2020, the company and Edwards
Lifesciences Foundation expect to invest approximately $30 million in this initiative.
"The Every Heartbeat Matters initiative brings together
passionate and innovative people to share bright ideas and create
partnerships to solve critical issues facing underserved
populations at risk of heart valve disease," said José Tomás Pérez,
Ambassador Extraordinary and Plenipotentiary of the Dominican
Republic, Washington, D.C. "In the
Dominican Republic, where the
burden of heart valve disease is especially high, both the
financial and non-financial support of Every Heartbeat Matters
helps to care for those suffering from this life-threatening
condition."
Since Every Heartbeat Matters launched in 2014:
- 60 non-profit partners joined the initiative
- The initiative has reached underserved people in more than 40
countries
- Approximately 1.2 million underserved people have been impacted
by public health education
- More than 24,000 clinicians have received education to elevate
care for underserved patients
- More than 110,000 underserved people have been screened for
heart valve disease with approximately 6 percent of the population
diagnosed and referred for charitable care
- Most significantly, almost 7,000 underserved people received
life-saving heart valve treatment
Request for Proposals
Edwards Lifesciences Foundation
is accepting requests for funding from non-profit organizations to
partner on programs for its Every Heartbeat Matters initiative or
those that strengthen the communities in which Edwards' employees
live and work. The foundation's 2019 grant cycle is open May
13 to June 28, and grant applications and other information,
including a complete listing of all grants issued, are available
at edwards.com/corporategiving. Visit the Edwards
Lifesciences YouTube channel to learn more about the impact of
global giving and the journey of several patients, who were
supported by Edwards employees and received transformative
care.
About Edwards Lifesciences and Edwards Lifesciences
Foundation
Edwards Lifesciences, based in Irvine,
Calif., is the global leader in patient-focused medical innovations
for structural heart disease, as well as critical care and surgical
monitoring. Driven by a passion to help patients, the company
collaborates with the world's leading clinicians and researchers to
address unmet healthcare needs, working to improve patient outcomes
and enhance lives. For more information,
visit www.edwards.com and follow us on Twitter
@EdwardsLifesci. In 2004, the company established what is now
Edwards Lifesciences Foundation. The foundation focuses on
supporting underserved heart valve and critically ill patients, as
well as strengthening the communities in which Edwards employees
live and work. Since its inception, the foundation has gifted more
than $60 million to non-profit organizations. Additional
information can be found at Edwards.com/CorporateGiving.
This news release includes forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933 and Section
21E of the Securities Exchange Act of 1934. These forward-looking
statements include, but are not limited to, statements by Mr. Pérez
and Ms. Fowler and expectations regarding the timing and scope of
the initiative's impact. Forward-looking statements are based on
estimates and assumptions made by management of the company and are
believed to be reasonable, though they are inherently uncertain and
difficult to predict. Our forward-looking statements speak only as
of the date on which they are made and we do not undertake any
obligation to update any forward-looking statement to reflect
events or circumstances after the date of the statement.
Forward-looking statements involve risks and uncertainties that
could cause results to differ materially from those expressed or
implied by the forward-looking statements based on a number of
factors, including but not limited to, unanticipated delays or
changes to the Every Heartbeat Matters initiatives. These and other
additional factors are detailed in the company's filings with the
Securities and Exchange Commission including its Annual Report on
Form 10-K for the year ended December 31, 2018. These filings,
along with important safety information about our products, may be
found at www.edwards.com.
Edwards, Edwards Lifesciences, the stylized E logo and Every
Heartbeat Matters are trademarks of Edwards Lifesciences
Corporation. All other trademarks are the property of their
respective owners.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/edwards-lifesciences-every-heartbeat-matters-charitable-initiative-on-track-to-impact-1-5-million-underserved-people-by-2020--300850545.html
SOURCE Edwards Lifesciences Corporation